Administration of Sublingual Nitroglycerin in Patients with Unknown Chest Pain

Critical Safety Parameters and Administration Protocol

The American Heart Association recommends that sublingual nitroglycerin can be considered in select hemodynamically stable patients with suspected acute coronary syndrome (ACS), with systolic blood pressure ≥90 mmHg and heart rate 50-100 bpm, and without clear contraindications, as it provides effective pain relief and is safe when properly monitored 1, 2, 4
The American Heart Association explicitly states that it is reasonable to consider early nitroglycerin administration in select hemodynamically stable patients with suspected ACS, though insufficient evidence exists to support routine administration 1, 4
Patients should not receive nitroglycerin if they have recently used PDE-5 inhibitors, such as sildenafil within 24 hours or tadalafil within 48 hours, or if they have suspected right ventricular infarction 4
The dosing regimen for sublingual nitroglycerin is 0.3-0.4 mg dissolved under the tongue, which may be repeated every 5 minutes for a maximum of 3 doses if chest pain persists 1, 2

The European Society of Cardiology warns that nitroglycerin response can be misleading and should not be used to distinguish cardiac from non-cardiac chest pain, and that patients still require full cardiac evaluation with ECG within 10 minutes and serial troponins regardless of nitroglycerin response 5, 6
The American Heart Association recommends that aspirin 162-325 mg (chewed, non-enteric) should be administered immediately unless there is a true allergy or active GI bleeding, and that patients should be established on continuous cardiac monitoring 1, 4, 6
Initial cardiac troponin (preferably high-sensitivity) should be drawn with repeat at 3-6 hours, and a 12-lead ECG should be obtained within 10 minutes to look for ST-elevation, new Q-waves, T-wave inversions, or ST-depression 5, 6

If pain is unresponsive to nitroglycerin, IV morphine may be considered as the preferred analgesic for persistent ischemic chest pain, though use with caution as morphine has been associated with increased mortality in unstable angina/NSTEMI registries 1, 3, 4
Elderly patients, women, and diabetics may present with atypical symptoms such as dyspnea, nausea, or fatigue rather than classic chest pain, and should not be delayed for cardiac evaluation 5